Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act

This publication has 29 references indexed in Scilit:

• Obesity as an aggravating factor of systemic lupus erythematosus disease: What we already know and what we must explore. A rapid scoping review
  Nutrition, 2024
• Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
  JAMA, 2024
• Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
  The Lancet, 2023
• Obesity defined molecular endotypes in the synovium of patients with osteoarthritis provides a rationale for therapeutic targeting of fibroblast subsets
  Clinical and Translational Medicine, 2023
• Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
  Clinical Rheumatology, 2022
• Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis
  Seminars in Arthritis and Rheumatism, 2021
• The drive to eat in homo sapiens: Energy expenditure drives energy intake
  Physiology & Behavior, 2020
• Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
  The Lancet Diabetes & Endocrinology, 2019
• Foundations of Immunometabolism and Implications for Metabolic Health and Disease
  Immunity, 2017
• Chronic widespread pain in the spectrum of rheumatological diseases
  Best Practice & Research Clinical Rheumatology, 2011